Abstract
Ciprofloxacin was administered to 12 healthy male volunteers at doses of 300 and 400 mg intravenously (i.v.) and 500 and 750 mg orally in a randomized, double-blind, single-dose, four-period crossover study. On each treatment day, each subject received both oral and i.v. formulations, one of which was a placebo. Blood and urine samples were obtained through 24 h postdose. By each dosing route, the pharmacokinetic profiles were dose proportional. The 400-mg i.v. dose was equivalent to the 500-mg oral dose with respect to the area under the concentration-time curve and was equivalent to the 750-mg oral dose with respect to the maximum concentration of ciprofloxacin in serum. The oral bioavailability was 78.0%. The steady-state volume of distribution averaged 178 liters, and the terminal half-life in serum after i.v. dosing was approximately 4.3 h. Renal clearance accounted for approximately 60% of total body clearance. No significant adverse events were associated with either route of administration.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Arcieri G., August R., Becker N., Doyle C., Griffith E., Gruenwaldt G., Heyd A., O'Brien B. Clinical experience with ciprofloxacin in the USA. Eur J Clin Microbiol. 1986 Apr;5(2):220–225. doi: 10.1007/BF02013994. [DOI] [PubMed] [Google Scholar]
- Aronoff G. E., Kenner C. H., Sloan R. S., Pottratz S. T. Multiple-dose ciprofloxacin kinetics in normal subjects. Clin Pharmacol Ther. 1984 Sep;36(3):384–388. doi: 10.1038/clpt.1984.192. [DOI] [PubMed] [Google Scholar]
- Bauernfeind A., Petermüller C. In vitro activity of ciprofloxacin, norfloxacin and nalidixic acid. Eur J Clin Microbiol. 1983 Apr;2(2):111–115. doi: 10.1007/BF02001575. [DOI] [PubMed] [Google Scholar]
- Bergan T., Thorsteinsson S. B., Kolstad I. M., Johnsen S. Pharmacokinetics of ciprofloxacin after intravenous and increasing oral doses. Eur J Clin Microbiol. 1986 Apr;5(2):187–192. doi: 10.1007/BF02013984. [DOI] [PubMed] [Google Scholar]
- Borner K., Höffken G., Lode H., Koeppe P., Prinzing C., Glatzel P., Wiley R., Olschewski P., Sievers B., Reinitz D. Pharmacokinetics of ciprofloxacin in healthy volunteers after oral and intravenous administration. Eur J Clin Microbiol. 1986 Apr;5(2):179–186. doi: 10.1007/BF02013983. [DOI] [PubMed] [Google Scholar]
- Gleadhill I. C., Ferguson W. P., Lowry R. C. Efficacy and safety of ciprofloxacin in patients with respiratory infections in comparison with amoxycillin. J Antimicrob Chemother. 1986 Nov;18 (Suppl 500):133–138. doi: 10.1093/jac/18.supplement_d.133. [DOI] [PubMed] [Google Scholar]
- Guay D. R., Awni W. M., Peterson P. K., Obaid S., Breitenbucher R., Matzke G. R. Pharmacokinetics of ciprofloxacin in acutely ill and convalescent elderly patients. Am J Med. 1987 Apr 27;82(4A):124–129. [PubMed] [Google Scholar]
- Mandallaz D., Mau J. Comparison of different methods for decision-making in bioequivalence assessment. Biometrics. 1981 Jun;37(2):213–222. [PubMed] [Google Scholar]
- Reeves D. S., Bywater M. J., Holt H. A., White L. O. In-vitro studies with ciprofloxacin, a new 4-quinolone compound. J Antimicrob Chemother. 1984 Apr;13(4):333–346. doi: 10.1093/jac/13.4.333. [DOI] [PubMed] [Google Scholar]
- Riegelman S., Collier P. The application of statistical moment theory to the evaluation of in vivo dissolution time and absorption time. J Pharmacokinet Biopharm. 1980 Oct;8(5):509–534. doi: 10.1007/BF01059549. [DOI] [PubMed] [Google Scholar]
- Schwartzman M. S., Franck W. A. Vitamin D toxicity complicating the treatment of senile, postmenopausal, and glucocorticoid-induced osteoporosis. Four case reports and a critical commentary on the use of vitamin D in these disorders. Am J Med. 1987 Feb;82(2):224–230. doi: 10.1016/0002-9343(87)90060-x. [DOI] [PubMed] [Google Scholar]
- Wise R., Andrews J. M., Edwards L. J. In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents. Antimicrob Agents Chemother. 1983 Apr;23(4):559–564. doi: 10.1128/aac.23.4.559. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wise R., Donovan I. A. Tissue penetration and metabolism of ciprofloxacin. Am J Med. 1987 Apr 27;82(4A):103–107. [PubMed] [Google Scholar]